HDAC9 and diffuse large B-cell lymphoma: All three acquired venetoclax-resistant and their parental venetoclax-sensitive DLBCL lines were equally sensitive (had analogous IC50s) to HDAC inhibition, with the greatest sensitivity to romidepsin followed by panobinostat and then vorinostat (Supplementary Figure S3C).